GRI Bio, Inc.
GRI
$2.31
$0.062.67%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -45.68% | -36.09% | -20.90% | 26.68% | 37.05% |
| Total Depreciation and Amortization | 0.00% | 111.43% | 0.00% | 150.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2,002.50% | 775.83% | 331.82% | -24.75% | -84.56% |
| Change in Net Operating Assets | 306.47% | 132.39% | 115.02% | 7.10% | -126.67% |
| Cash from Operations | -18.29% | 24.30% | 18.24% | 23.27% | 4.22% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 12.23% | -13.49% | -10.65% | -52.91% | 13.07% |
| Repurchase of Common Stock | -100.00% | 0.00% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -6.69% | -172.77% | -160.89% | 70.68% | 24.98% |
| Cash from Financing | 13.18% | -36.54% | -37.83% | -48.54% | 9.58% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -0.59% | -154.93% | -179.21% | -122.31% | 78.99% |